CAC 40 Stalls at Midday, Paralyzed by Anticipation of Fed Decision

Tech and Defense Heavyweights Come to the Rescue

If the CAC 40 dips into the red, it's only by the narrowest of margins, and for good reason: the leading players on the Paris market are showing exemplary resilience. Thales leads the charge with an impressive performance, up 3.13%, benefiting from momentum that seems detached from the prevailing pessimism. Crédit Agricole gains 1.63%, solidifying its position among sought-after defensive stocks, while Capgemini rises 1.34%, fueled by the prospects in the tech sector despite macroeconomic turbulence. BNP Paribas follows suit with an increase of 1.30%, confirming that top-tier banks attract investors during downturns. Euronext gains 1.26%, benefiting from the persistent appeal of stock exchange infrastructure. This performance by CAC 40 giants reveals a clear allocation strategy: investors are flocking to quality stocks, those with financial solidity and proven business models. Edenred and ArcelorMittal complete this picture of relative stability, with respective gains of 1.18% and 1.14%, while other cyclical sectors and those more sensitive to interest rate fluctuations remain outside today's largesse.

Luxury and regulatory defense pay a high price

On the other hand, the luxury sector is experiencing a particularly challenging dry spell. EssilorLuxottica recorded the largest drop in the index with a 4.42% plunge, while Kering lost ground with a 2.19% decline, both affected by a reevaluation of consumer outlook in this sector. LVMH shares were not spared, falling 1.25%, rounding out an unfortunate trio that encapsulates the current challenges in the sector: wavering demand from affluent customers amid macroeconomic uncertainties.

The regulatory defense sector is also under tangible pressure. Schneider Electric dropped 1.89%, burdened by concerns over its portfolio and investment prospects. Bureau Veritas conceded a 1.44% decrease, while Sanofi fell 1.30%, the latter being downgraded to a neutral rating by JPMorgan, which questions the real impact of future clinical trial results. These declines highlight the market's selectivity, favoring defensive stocks over those considered more vulnerable to economic fluctuations. Air Liquide and Saint-Gobain also saw declines of 1.05% and 1.06% respectively, confirming the trend of disappointment among traditional industry players in the face of weakened outlooks.

A Market Caught Between Caution and Volatility

The market setup reveals a status quo, characteristic of periods preceding major monetary decisions. Observers agree that the Fed is expected to lower rates by a quarter point, setting the target range between 3.50% and 3.75%. However, the nuances in Powell's discourse and the economic projections from the American institution are of paramount importance. The market is carefully evaluating signals related to a potential halt in rate cuts as early as January 2026, an element that could reshape asset allocation trajectories. Meanwhile, the French market lacks major domestic catalysts.

France's ten-year bond shows persistent tension at 3.58%, reflecting concerns surrounding the fiscal and monetary context. This climate of uncertainty is conducive to tactical research and sector rotations, rather than large-scale shifts. The decreasing performance of minor winners and losers indicates that confidence remains mixed. Few stocks exceed a 3% gain, while losses are mostly contained under 5%, except for Essilorluxottica. This seesaw configuration reflects the prevailing indecision in trading rooms, where everyone is awaiting the Fed's signal to decisively arbitrate between aggression and caution.